Learn more

FEDERAL NOE G BJUDZHETNOE UCHREZHDENIE NAUKI INST MOLEKULJARNOJ BIOLOG IM V A EHNGEL GARDTA ROSSIJSK

Overview
  • Total Patents
    25
  • GoodIP Patent Rank
    199,694
About

FEDERAL NOE G BJUDZHETNOE UCHREZHDENIE NAUKI INST MOLEKULJARNOJ BIOLOG IM V A EHNGEL GARDTA ROSSIJSK has a total of 25 patent applications. Its first patent ever was published in 2011. It filed its patents most often in Russian Federation. Its main competitors in its focus markets pharmaceuticals and environmental technology are TOYO PHARMA KK, UNIV CHINA PHARMACY and NIHON REDARII KK.

Patent filings in countries

World map showing FEDERAL NOE G BJUDZHETNOE UCHREZHDENIE NAUKI INST MOLEKULJARNOJ BIOLOG IM V A EHNGEL GARDTA ROSSIJSKs patent filings in countries
# Country Total Patents
#1 Russian Federation 25

Patent filings per year

Chart showing FEDERAL NOE G BJUDZHETNOE UCHREZHDENIE NAUKI INST MOLEKULJARNOJ BIOLOG IM V A EHNGEL GARDTA ROSSIJSKs patent filings per year from 1900 to 2020

Focus industries

Top inventors

# Name Total Patents
#1 Makarov Aleksandr Aleksandrovich 6
#2 Tsvetkov Filipp Olegovich 4
#3 Kozin Sergej Aleksandrovich 4
#4 Kochetkov Sergej Nikolaevich 3
#5 Kudrjavtseva Anna Viktorovna 3
#6 Mit Kevich Vladimir Aleksandrovich 3
#7 Kretova Ol Ga Valer Evna 3
#8 Mel Nikova Natalija Vladimirovna 3
#9 Churikov Nikolaj Andreevich 3
#10 Dmitriev Aleksej Aleksandrovich 3

Latest patents

Publication Filing date Title
RU2562866C1 Detection method of dna of tuberculosis causative agent with simultaneous identification of its genotype and determination of genetic determinants of multiple and wide drug resistance, oligonucleotide microchip, set of primers and set of oligonucleotide probes, which are used in method
RU2552483C1 Method of analysis of somatic mutations in genes egfr, kras and braf using lna-blocking multiplex pcr and subsequent hybridisation with oligonucleotide biological microchip (biochip)
RU2573450C1 Method of identifying target genes for diagnostics and therapy of human leucoses
RU2567670C2 Preparation for selective apoptotic elimination of tumour cells
RU2552487C2 Attenuated strain of sendai virus
RU2548759C2 Diagnostic technique for alzheimer disease by measuring chemically modified forms of metal-binding beta-amyloid domain in biological fluids
RU2573924C2 NON-TOXIC RECOMBINANT SHIGA TOXIN TYPE 2 (Stx2)
RU2544958C2 METHOD FOR CELL PROTECTION AGAINST HYPOXIC INJURY BY GLUTATHIONYLATION OF Na, K-ADENOSINE TRIPHOSPHATASE CATALYTIC SUBUNIT
RU2558953C2 (r,r)- and (s,s)-diastereomers of 2,11-dimethylspermine and 3,10-dimethylspermine
RU2567303C2 Method for transplantation of human cell with application of microtransplants (mct), consisting of fibrous polyglycolic microcarrier and fibroblast-like cells attached to it
RU2544957C2 Method for developing alzheimer disease cell models
RU2517173C1 NOVEL 5-MODIFIED PYRIMIDINE NUCLEOSIDES - Mycobacterium tuberculosis GROWTH INHIBITORS
RU2552486C2 CARTRIDGE GENETIC CONSTRUCT EXPRESSING TWO BIOLOGICALLY ACTIVE siRNAS EFFECTIVELY ATTACKING SUBTYPE A HIV-1 TRANSCRIPTS TARGETED TO iRNA OF REVERSE TRANSCRIPTASE AND INTEGRASE, AND ONE siRNA TARGETED TO iRNA OF CCR5 GENE IN RUSSIAN PATIENTS
RU2532525C2 Exogenic-induced animal model of alzheimer disease
RU2558952C2 (r)- and (s)-isomers of 3-methylspermidine
RU2532843C2 Diagnostic technique for influenza c
RU2530601C2 Zinc-dependent beta-amyloid dimer formation inhibitor
RU2545998C2 Method of diagnosing clear cell renal cell carcinoma and set for its realisation
RU2552607C2 CARTRIDGE GENETIC CONSTRUCT EXPRESSING TWO BIOLOGICALLY ACTIVE siRNAS EFFECTIVELY ATTACKING SUBTYPE A HIV-1 TRANSCRIPTS, AND ONE siRNA TARGETED TO iRNA OF CCR5 GENE IN RUSSIAN PATIENTS
RU2527457C2 Inhibitors of human poly(adp-riboso)polymerase-1 based on uracyl derivatives